| Dr Neil A Nadkarni, MD | |
|
Sbumc Hsc Level 12, Rm 020, Stony Brook, NY 11794-8121 | |
| (631) 444-8118 | |
| (631) 759-2750 |
| Full Name | Dr Neil A Nadkarni |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 10 Years |
| Location | Sbumc Hsc Level 12, Rm 020, Stony Brook, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306264478 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084A2900X | Psychiatry & Neurology - Neurocritical Care | 319187 (New York) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | 319187 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Suny/stony Brook University Hospital | Stony brook, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Neurology Associates Of Stony Brook, University Faculty Practice Corpo | 5193617116 | 44 |
News Archive
Cardiva Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the VASCADE Vascular Closure System (VCS).
The Globe and Mail examines GlaxoSmithKline's RTS,S malaria vaccine trials in Kilifi, Kenya – one of the sites where the experimental vaccine is being tested. "The stories of the mothers of Kilifi open a window on the challenges faced by researchers as they build a trial that will include more than 16,000 babies from 11 sites spread across sub-Saharan Africa," the Globe and Mail reports.
A drug created from a malaria protein stopped tumor growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.
On Monday, President Donald Trump claimed that the World Health Organization (WHO) "admitted" he was correct that using lockdowns to control the spread of COVID-19 was more damaging than the illness.
› Verified 7 days ago
| Entity Name | Neurology Associates Of Stony Brook, University Faculty Practice Corpo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699720888 PECOS PAC ID: 5193617116 Enrollment ID: O20040325001262 |
News Archive
Cardiva Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the VASCADE Vascular Closure System (VCS).
The Globe and Mail examines GlaxoSmithKline's RTS,S malaria vaccine trials in Kilifi, Kenya – one of the sites where the experimental vaccine is being tested. "The stories of the mothers of Kilifi open a window on the challenges faced by researchers as they build a trial that will include more than 16,000 babies from 11 sites spread across sub-Saharan Africa," the Globe and Mail reports.
A drug created from a malaria protein stopped tumor growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.
On Monday, President Donald Trump claimed that the World Health Organization (WHO) "admitted" he was correct that using lockdowns to control the spread of COVID-19 was more damaging than the illness.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Neil A Nadkarni, MD Sbumc Hsc Level 12, Rm 020, Stony Brook, NY 11794-8121 Ph: (631) 444-8118 | Dr Neil A Nadkarni, MD Sbumc Hsc Level 12, Rm 020, Stony Brook, NY 11794-8121 Ph: (631) 444-8118 |
News Archive
Cardiva Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the VASCADE Vascular Closure System (VCS).
The Globe and Mail examines GlaxoSmithKline's RTS,S malaria vaccine trials in Kilifi, Kenya – one of the sites where the experimental vaccine is being tested. "The stories of the mothers of Kilifi open a window on the challenges faced by researchers as they build a trial that will include more than 16,000 babies from 11 sites spread across sub-Saharan Africa," the Globe and Mail reports.
A drug created from a malaria protein stopped tumor growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.
On Monday, President Donald Trump claimed that the World Health Organization (WHO) "admitted" he was correct that using lockdowns to control the spread of COVID-19 was more damaging than the illness.
› Verified 7 days ago
Dr. Maged Sobhy Soliman, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Child And Adolescent Psychiatry Outpatient Department, 169 Putnam Hall, Stony Brook, NY 11794 Phone: 631-632-8850 | |
Dr. Adeeb Yacoub, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Health Sciences Center -, T10, Stony Brook, NY 11794 Phone: 631-444-6050 | |
Kamil Stefanowski, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 101 Nicolls Rd, Stony Brook, NY 11794 Phone: 631-444-2599 | |
Dr. Brian Ghezelaiagh, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2500 Nesconset Hwy Bldg 17c, Stony Brook, NY 11790 Phone: 631-210-6305 Fax: 631-292-7376 | |
Dr. Mark Sedler, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Health Sciences Center - T10, Stony Brook, NY 11790 Phone: 631-444-2571 | |
Dr. Zoya Popivker, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Department Of Psychiatry, Putnam Hall, Suny At Stony Brook, Stony Brook, NY 11794 Phone: 631-632-8850 Fax: 631-632-4448 | |
Lourdes Alicia Bello Espinosa, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Stony Brook University Hsc T12 020, Stony Brook, NY 11794 Phone: 631-444-2599 |